The duration is supported by Hauser RG et al. [18] who investigated 1,623 patients underwent M-BCR testing for CML diagnosis and had at least six consecutive years of FBC with differentials prior to CML diagnosis. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.